Literature DB >> 16769193

Cephalosporin resistance in Klebsiella pneumoniae from Nova Scotia, Canada.

Roberto G Melano1, Ross J Davidson, Heather L Musgrave, Kevin R Forward.   

Abstract

From 2116 Klebsiella pneumoniae strains isolated between January 2001 and December 2002 in Nova Scotia, Canada, 25 (1.18%) showed a reduced susceptibility to cefoxitin or extended-spectrum cephalosporins. Narrow-spectrum beta-lactamase genes (bla(SHV-11), bla(SHV-1), bla(SHV-26), bla(SHV-32), bla(SHV-36), and bla(SHV-40)) were the most prevalent. Four new variants were identified (bla(LEN-17), bla(OKP-B-13), bla(OKP-B-14), and bla(OKP-A-11)), representing the 1st description of bla(OKP) in the Americas. Among the extended-spectrum beta-lactamase (ESBL) genes, bla(SHV-2), bla(SHV2a), bla(SHV-12), and bla(CTX-M-15) were detected (ESBL prevalence of 0.14%). Nineteen strains were resistant to cefoxitin (MIC, 32 to >256 microg/mL). Nevertheless, an AmpC-like activity was detected in only 1 strain, which expressed CMY-2. The combined effects of narrow-spectrum beta-lactamase production and decreased or nonexpression of OmpK35/36 porins did not account for the cefoxitin resistance observed in some of these strains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769193     DOI: 10.1016/j.diagmicrobio.2006.04.016

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  2 in total

1.  Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae.

Authors:  Christine Seah; Donald E Low; Samir N Patel; Roberto G Melano
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

2.  ESBLs: A Clear and Present Danger?

Authors:  Rishi H-P Dhillon; John Clark
Journal:  Crit Care Res Pract       Date:  2011-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.